EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY-NC 3.0

Sputum Microbiome, Potentially Pathogenic Organisms, and Clinical Outcomes in Japanese Patients with COPD and Moderate Airflow Limitation: The Prospective AERIS-J Study

Kazuhiro Yatera, Zhang Wang, Yoko Shibata iD, Nobuhisa Ishikawa iD, Tetsuya Homma, Kiyoyasu Fukushima iD, Osamu Hataji iD, Yoshikazu Inoue iD, Hiroki Kawabata, Keisuke Miki iD, Kazuhiro Sato iD, Kazunori Tobino und 7 weitere

International Journal of Chronic Obstructive Pulmonary Disease · 2025

DOI: 10.2147/copd.s481406 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift International Journal of Chronic Obstructive Pulmonary Disease, 2025. Verfasst von Kazuhiro Yatera und 18 weiteren Autor:innen. Beteiligte Einrichtung: University of Occupational and Environmental Health Japan, Fukuoka, Japan. Hauptthemen laut MEDLINE: Bacteria, Lung, Microbiota, Pulmonary Disease, Chronic Obstructive. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: GSK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In Western studies, lung microbiome changes are reported in patients with chronic obstructive pulmonary disease (COPD) and are associated with poorer outcomes, but similar studies in Asian patients or those with less severe COPD are limited.

Methods

The Acute Exacerbation and Respiratory InfectionS in COPD Japan (AERIS-J; jRCT1080224632/NCT03957577) was a prospective, non-interventional study to evaluate sputum microbiome diversity at baseline and after 12 months (V2; exploratory analysis), in patients aged 40-80 years with stable COPD (June 2019-June 2022). Baseline sputum potentially pathogenic organisms (PPOs) were identified. Blood cell counts and COPD Assessment Test (CAT) scores were collected at baseline and COPD symptoms measured over 12 months using the Evaluating Respiratory Symptoms in COPD and EXAcerbations of Chronic pulmonary disease Tool, collected by eDiary.

Results

Patients (N=63) had a mean age of 72.8 years, and percent predicted post-bronchodilator forced expiratory volume in 1 second was 58.3%; 92% were male. Across 62 baseline sputum samples, microbiome composition was similar between 16S rRNA/metagenomic datasets. Patients graded Global Initiative for Chronic Obstructive Lung Disease (GOLD) III versus GOLD I/II had minimal differences in their microbial taxonomic profile and no differences in microbial diversity (Wilcoxon P=0.71). Alpha diversity (Shannon index) positively correlated with blood basophils (rho=0.41; P=0.0019) and negatively correlated with CAT score (rho=0.36; P=0.0069). Alpha diversity and sputum (rho: -0.0637; P=0.7836) or blood (rho: 0.1739; P=0.2043) eosinophils were not correlated. No difference in alpha (P=0.5) or beta (P=0.3) diversity or Operational Taxonomic Unit (Anosim R=-0.024; P=0.892) was observed between PPO-positive or -negative sputum.

Conclusion

A less diverse microbiome correlated with poorer health status and lower blood basophils in patients with COPD and moderate airflow limitation. There was no relationship between PPO presence and microbiome diversity. Chronic obstructive pulmonary disease (COPD) is a progressive lung condition resulting in breathing difficulties. Research has shown that patients with COPD experience changes in the diversity of bacteria in their lungs, leading to a worsening of symptoms. The lung microbiome includes different types of bacteria, and is involved in important roles, such as regulating the immune system and protecting the lung from invading pathogens. Many studies on the microbiome have been based in western countries, and there are few studies among Asian patients and populations with moderate COPD. The aim of this year-long study was to assess the diversity of the lung microbiome in Japanese patients with COPD and moderate airflow limitation, and how it affects patients’ immunity and disease severity. Patients’ sputum and blood samples were obtained at the start of the study and the different types of bacteria in the sputum and the number of immune cells in the blood were measured. Patients’ symptoms were also assessed at study start. Results showed that a less diverse lung microbiome was associated with lower levels of blood immune cells and worse COPD symptoms. These results improve our knowledge of the lung microbiome in an Asian population with COPD, providing insights into how lower bacterial diversity may worsen patient immunity and COPD severity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BacteriaLungMicrobiotaPulmonary Disease, Chronic ObstructiveSputumAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedDisease ProgressionForced Expiratory VolumeJapanProspective StudiesSeverity of Illness IndexEast Asian People

Stichwörter der Autor:innen

16S rRNAAsiaCOPD assessment testbasophilmetagenomicsputum

Autor:innen und Institutionen

  • University of Occupational and Environmental Health Japan, Fukuoka, Japan.
  • Institute of Ecological Sciences, School of Life Sciences, South China Normal University, Guangzhou, People's Republic of China.
  • Fukushima Medical University, Fukushima, Japan.
  • Hiroshima Prefectural Hospital, Hiroshima, Japan.
  • Showa University School of Medicine, Tokyo, Japan.
  • Japanese Red Cross, Nagasaki Genbaku Isahaya Hospital, Nagasaki, Japan.

ORCID-Profile: Yoko Shibata, Nobuhisa Ishikawa, Kiyoyasu Fukushima, Osamu Hataji, Yoshikazu Inoue, Keisuke Miki, Kazuhiro Sato, Makoto Yoshida, Risako Ito, Shinya Kawamatsu, Chris H Compton, Paul W Jones

Förderung

  • GSK

Zitieren

APA

Yatera, K., Wang, Z., Shibata, Y., Ishikawa, N., Homma, T., Fukushima, K., Hataji, O., Inoue, Y., Kawabata, H., Miki, K., Sato, K., Tobino, K., Yoshida, M., Ishii, T., Ito, R., Kobayashi, T., Kawamatsu, S., Compton, C. H., & Jones, P. W. (2025). Sputum Microbiome, Potentially Pathogenic Organisms, and Clinical Outcomes in Japanese Patients with COPD and Moderate Airflow Limitation: The Prospective AERIS-J Study. International Journal of Chronic Obstructive Pulmonary Disease. https://doi.org/10.2147/copd.s481406

Vancouver

Yatera K, Wang Z, Shibata Y, Ishikawa N, Homma T, Fukushima K, et al. Sputum Microbiome, Potentially Pathogenic Organisms, and Clinical Outcomes in Japanese Patients with COPD and Moderate Airflow Limitation: The Prospective AERIS-J Study. International Journal of Chronic Obstructive Pulmonary Disease. 2025. doi:10.2147/copd.s481406

BibTeX
@article{Yatera2025,
  author = {Yatera, Kazuhiro and Wang, Zhang and Shibata, Yoko and Ishikawa, Nobuhisa and Homma, Tetsuya and Fukushima, Kiyoyasu and Hataji, Osamu and Inoue, Yoshikazu and Kawabata, Hiroki and Miki, Keisuke and Sato, Kazuhiro and Tobino, Kazunori and Yoshida, Makoto and Ishii, Takeo and Ito, Risako and Kobayashi, Tamami and Kawamatsu, Shinya and Compton, Chris H and Jones, Paul W},
  title = {Sputum Microbiome, Potentially Pathogenic Organisms, and Clinical Outcomes in Japanese Patients with COPD and Moderate Airflow Limitation: The Prospective AERIS-J Study},
  journal = {International Journal of Chronic Obstructive Pulmonary Disease},
  year = {2025},
  doi = {10.2147/copd.s481406}
}
Kostenlos starten →